The Rising Cancer Rates Among Millennial Women
A federal appeals court has ruled to roll back mail-order access to the abortion pill, mifepristone, and reverse other FDA actions related to its prescription. The court argued that the FDA failed to consider safety concerns by loosening restrictions. The ruling could lead to the Supreme Court weighing in on the issue, potentially impacting access to the abortion pill during the upcoming election season.